News | Computed Tomography (CT) | March 04, 2019

Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool

Aidoc’s solution flags and prioritizes pulmonary embolisms found in CT pulmonary angiograms

Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool

March 4, 2019 — Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked product for the identification and triage of pulmonary embolism (PE) in computed tomography (CT) pulmonary angiograms. By flagging obstructions in blood-flow to the lungs, Aidoc prioritizes radiologists’ work queues and helps them detect critical conditions faster, leading to quicker treatment and saving lives.

In the United States alone, up to 600,000 people are diagnosed with PE annually and it is estimated to be responsible for 100,000 annual deaths, making it the third most common cause of cardiovascular death. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making the case that it can truly benefit from AI-driven workflow triage.

At the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, Aidoc ]demonstrated its suite of AI-based workflow solutions. The diagnostic performance of Aidoc’s PE solution at the University Hospital of Basel was presented as part of the ECR scientific sessions, demonstrating research concluding that Aidoc can complement conventional workflows with worklist prioritization and has the potential to improve the quality of healthcare by accelerating the diagnostic process and communication.

Read the abstract and watch the recorded ECR presentation here.

For more information: www.aidoc.com

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 08, 2020 | By Melinda Taschetta-Millane
Moblie C-arms have seen several advances over the past de
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for